doi: 10.1161/01.HYP.0000114697.14697.d2
(Hypertension. 2004;43:198.)
© 2004 American Heart Association, Inc.
Scientific Contributions |
Guidelines for Hypertension: Are Quality-Assurance Measures on Target?
From Rush University Hypertension Service, Chicago, Ill.
Correspondence to Dr Henry R. Black, Department of Preventive Medicine, Rush-Presbyterian St. Luke’s Medical Center, 1700 West Van Buren, Suite 470, Chicago, IL 60612. E-mail hblack{at}rush.edu
Guideline committees recommend targets of treatment based on trial data on efficacy and effectiveness. Quality-assurance initiatives apply these parameters in the general practice setting. Therefore, targets must be feasible and achievable by the practicing physicians who are judged by these targets as goals for care. We evaluated 437 patients in the Rush University Hypertension Clinic using the Health Employer Data Information Set (HEDIS) measures for 2000 to assess goal achievement in a practice-based setting. We compared guideline achievement of uncomplicated hypertensive and diabetic subjects to standards dictated by HEDIS, the 6th Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI), and the American Diabetic Association (ADA)/National Kidney Foundation (NKF). Overall, 276 (63%) patients achieved SBP goal, with 376 (86%) achieving DBP goal and 358 (59%) achieving both goals. However, in the 20% of patients who were diabetic, only 52% had a BP of <140 mm Hg and <90 mm Hg, whereas only 22% achieved the more stringent goals of JNC VI of <130 mm Hg systolic and <85 mm Hg diastolic and only 15% achieved the ADA/NKF goals of <130 mm Hg systolic and <80 mm Hg diastolic. Although goal was achievable in most uncomplicated hypertension, hypertension in diabetes was more difficult to control, despite being more likely to receive enhanced benefit from effective management. Goal-oriented strategy, especially in diabetic subjects, should be aggressively sought rather than relaxing goals to promote achievement.
Key Words: hypertension • diabetes mellitus • clinical trials • blood pressure
This article has been cited by other articles:
 |
|
 |
|
  L. P. Svetkey, K. I. Pollak, W. S. Yancy Jr, R. J. Dolor, B. C. Batch, G. Samsa, D. B. Matchar, and P.-H. Lin Hypertension Improvement Project: Randomized Trial of Quality Improvement for Physicians and Lifestyle Modification for Patients Hypertension, December 1, 2009; 54(6): 1226 - 1233. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Will Intention and outcome in guideline-based nephrological practice: a suitable space for 'clinical technology' Nephrol. Dial. Transplant., November 1, 2007; 22(11): 3110 - 3114. [Full Text] [PDF]
|
|
|
|
 |
|
 D. O. Francis, H. Beckman, J. Chamberlain, G. Partridge, and R. A. Greene Introducing a Multifaceted Intervention to Improve the Management of Otitis Media: How Do Pediatricians, Internists, and Family Physicians Respond? American Journal of Medical Quality, March 1, 2006; 21(2): 134 - 143. [Abstract] [PDF]
|
|
|
|
 |
|
 T. J. Wang and R. S. Vasan Epidemiology of Uncontrolled Hypertension in the United States Circulation, September 13, 2005; 112(11): 1651 - 1662. [Full Text] [PDF]
|
|
|
|
|
|
P. S. Wang, J. Avorn, M. A. Brookhart, H. Mogun, S. Schneeweiss, M. A. Fischer, and R. J. Glynn Effects of Noncardiovascular Comorbidities on Antihypertensive Use in Elderly Hypertensives Hypertension, August 1, 2005; 46(2): 273 - 279. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. S. Brooks and J. R. Sowers Importance of Achieving Lower Blood Pressure in Hypertensive Patients With Diabetes Hypertension, November 1, 2004; 44(5): 614 - 615. [Full Text] [PDF]
|
|
|
|
|
|
G. L. Bakris, E. Gaxiola, F. H. Messerli, G. Mancia, S. Erdine, R. Cooper-DeHoff, C. J. Pepine, and for the INVEST Investigators Clinical Outcomes in the Diabetes Cohort of the International Verapamil SR-Trandolapril Study Hypertension, November 1, 2004; 44(5): 637 - 642. [Abstract] [Full Text] [PDF]
|
|